Krebs Biochemicals & Industries Limited (BOM:524518)
India · Delayed Price · Currency is INR 75.85
+3.10 (4.26%)
At close: Sep 10, 2025
BOM:524518 Revenue
Krebs Biochemicals & Industries had revenue of 54.81M INR in the quarter ending June 30, 2025, a decrease of -57.48%. This brings the company's revenue in the last twelve months to 359.04M, down -31.91% year-over-year. In the fiscal year ending March 31, 2025, Krebs Biochemicals & Industries had annual revenue of 433.12M, down -14.10%.
Revenue (ttm)
359.04M
Revenue Growth
-31.91%
P/S Ratio
4.64
Revenue / Employee
1.78M
Employees
202
Market Cap
1.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 433.12M | -71.10M | -14.10% |
| Mar 31, 2024 | 504.22M | -17.13M | -3.29% |
| Mar 31, 2023 | 521.34M | -75.69M | -12.68% |
| Mar 31, 2022 | 597.03M | 70.20M | 13.32% |
| Mar 31, 2021 | 526.84M | 202.88M | 62.63% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |
Krebs Biochemicals & Industries News
- 7 months ago - Krebs Biochemicals & Industries halts production following order from Andhra Pradesh Pollution Control Board - Business Upturn